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The association of megaloblastic anaemia with anticonvulsant therapy was first reported by Mannheimer, Pakesch, Reimer, and Vetter (1952) . Since then some cases of megaloblastic anaemia associated with a variety of anticonvulsants have been reported. The finding of normal levels of serum vitamin B12 and the repair of the anaemia which follows folic-acid therapy suggest that anticonvulsants affect folicacid metabolism. Further evidence for this has been the demonstration of macrocytosis or low serum folic-acid levels in about half the patients who have been on anticonvulsant drugs (Hawkins and Meynell, 1958; Klipstein, 1964) .
The influence of diet on the results of these surveys has not been clear. In order to investigate this, serum folic-acid and vitamin-B12 levels were studied in a group of epileptics and normal control subjects who were on identical and satisfactory diets.
Methods and Materials
The epileptic patients studied were in-patients at Chalfont Colony, Chalfont St. Peter, Buckinghamshire.
The great majority of patients were taking phenobarbitone and phenytoin. A few were receiving primidone instead of or in addition to phenytoin, and some were also being treated with Trinuride. There they take their meals in small groups supervised by ward sisters. The nursing staff are able, therefore, to know the dietary habits of each patient. Every patient studied was interviewed in the presence of the sister in charge, and this was particularly helpful in assessing the diet.
A 10% random sample of Chalfont Colony was taken after numbering all the patients and then selecting them by means of random numbers (Hill, 1961) . Forty-eight patients were chosen in this way; a further 12 who had been in poor health and who had been noted to have a low white blood cell count were also studied.
Twenty nursing sisters and ward staff were used as control subjects. They were all residents, and their diet was identical to that of the patients and was prepared in the same kitchens.
The levels of haemoglobin, haematocrit, mean corpuscular haemoglobin concentration, and mean corpuscular volume were estimated by the methods of Dacie (1964) . The assessment of macrocytosis was done independently by three observers who were unaware of the results of the serum folicacid assay.
The serum vitamin-B12 levels were determined by microbiological assay, Lactobacillus leichmannii being used as test organism (Spray, 1955) . By this method the normal range is 150-1,000 tqtg./ml. (Spray and Witts, 1958) ; values in the 20 control subjects in this study ranged from 250 to 920 /,4g./ml.
Serum folic acid was assayed with L. casei by the method described by Spray (1964) , which gave a normal range of 2.1-28 mtug./ml. The normal limits in the present group of control subjects were 2.1 to 10 mug./ml. In-vitro studies of the effect of anticonvulsant drugs showed that phenobarbitone and phenytoin sodium had no effect on the serum folic-acid assay when added to the medium in amounts comparable to those likely to occur in the extracts of the patients' sera.
Discussion
It now seems very likely that the macrocytosis and megaloblastic anaemia which may develop in patients on anticonvulsant therapy are due to an abnormality of folic-acid metabolism. Low levels of serum folic acid have been found by Kohn, Mollin, and Rosenbach (1961) and by Druskin, Wallen, and Bonagura (1962) in patients with megaloblastic anaemia due to anticonvulsants. Chanarin, Mollin, and Anderson (1958) showed a rapid clearance of folic acid from some of these cases, suggesting a deficiency of folic acid in the tissues. The low folic-acid levels observed are not due to an inhibitory effect on the assay; this repeated observation has been confirmed in the present study.
Macrocytosis or low serum folic-acid levels have been noted in patients on anticonvulsants for epilepsy secondary to focal brain damage (Hawkins and Meynell, 1958) . Four of our five cases of post-traumatic epilepsy showed low folic-acid levels ( Fig. 1) . It seems unlikely, therefore, that there is an inherent defect in folic-acid metabolism associated with cryptogenic epilepsy.
There is no evidence of impaired folic-acid absorption in epileptics. It has been shown that the urinary excretion of folic acid after a test dose (Girdwood, 1953 ) is normal in these cases (Girdwood, 1956 of these drugs suggest that anticonvulsants affect the metabolic pathway of folic acid (Christenson, Ultmann, and Roseman, 1957) . This direct action is supported by the haematological surveys of Hawkins and Meynell (1958) and Klipstein (1964) , and by the results of the present study.
The previous studies showed an incidence of 45 % of patients with abnormalities suggesting derangement of folicacid metabolism. In our randomly selected group on com- parable doses of the same anticonvulsants the incidence of macrocytosis was 11% and low serum folic-acid levels 37%/,. and Mollin, 1957). Hawkins and Meynell (1958) did not find significantly low levels of serum vitamin B12 in their patients.
Lees (1961) 
Summary
Haematological studies on a randomly selected group of epileptic patients on anticonvulsants have demonstrated an incidence of macrocytosis in 11% and of low serum folic-acid levels in 37%. Compared with a group of normal control subjects these patients had significantly low levels of serum folic acid and some reduction in serum vitamin B12* This study confirms that the primary cause of these phenomena is the anticonvulsant therapy, but comparison with previous surveys and with a group of less well nourished subjects suggests that an adequate diet may protect against the occurrence of macro- Most clinicians working in a large hospital in this country are unlikely to see more than one or two cases of amoebiasis a year. Between 1938 and 1964 63 patients were given a course of treatment for amoebiasis at the Radcliffe Infirmary, Oxford. In only 19 of these was the diagnosis established by the demonstration of Entamoeba histolytica in the stools or in biopsy specimens, but in the remainder a therapeutic trial of amoebicidal drugs was thought to be justified on clinical grounds.
In some patients amoebiasis presents little difficulty in diagnosis, as there is a history of bloody diarrhoea contracted abroad. In others the diagnosis may be missed, either because it is not considered or because the clinical features are unusual.
The present report deals with two cases of amoebic colitis and six cases of hepatic or pleuropulmonary amoebiasis seen here in recent years, all of which were a problem in diagnosis. Two were fatal, and in four others surgical procedures were carried out before the diagnosis was made.
Case 1 A man aged 34 was first seen at the ulcerative colitis clinic in November 1960 with a six-months history of diarrhoea with blood. At sigmoidoscopy the mucosa was hyperaemic and granular and a barium-enema examination was compatible with a diagnosis of ulcerative colitis. He was treated with a nightly rectal infusion of hydrocortisone hemisuccinate 100 mg., and within two weeks symptoms had regressed. In November 1962 there was a recurrence of symptoms with similar appearances at sigmoidoscopy, and a further course of local corticosteroids was given-again with improvement.
* Nuffield Department of Clinical Medicine, the Radcliffe Infirmary, Oxford.
In September 1964 he was admitted to hospital as an emergency because of massive rectal haemorrhage and fainting after two weeks of diarrhoea.
Sigmoidoscopy revealed mild but definite inflammation of the rectal mucosa, and treatment with systemic and local corticosteroids was begun. Barium-enema report (Dr. K. Lumsden): " There may be some inflammatory changes in the distal colon. . . . There is a constant filling defect in the caecum which appears to be due to an intraluminal mass of 'polypoid type '." A diagnosis of ulcerative colitis with a carcinoma of the caecum was made and a right hemicolectomy performed. There were several ulcers in the caecum (one of which perforated at the operation) and a mass of granulation tissue; microscopical examination showed deep ulceration with numerous E. histolytica in the lamina propria. A course of emetine hydrochloride by intramuscular injection was started on the sixth post-operative day and the corticosteroids were reduced, being finally stopped one week later. When questioned the patient said that he had served with the armed Forces in Burma from 1946 to 1948 but had not had an attpck of dysentery at the time.
Sigmoidoscopy three weeks after starting emetine was normal, but three months later, when he was having some looseness of the stools, the mucosa was fragile; stool examination and rectal biopsy were negative for amoebae. In the nine months that have since elapsed he has had no further bowel symptoms. 
